U.S. RESEARCH ROUNDUP Cognition Therapeutics, Mosaic, Shockwave Medical

1 minute read
Register now for FREE unlimited access to Reuters.com

Nov 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cognition Therapeutics, Mosaic and Shockwave Medical on Wednesday.

HIGHLIGHTS

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

Register now for FREE unlimited access to Reuters.com
Compiled by Bengaluru Newsroom

Our Standards: The Thomson Reuters Trust Principles.